From the Editor

News about serous ovarian Ca

Author and Disclosure Information

 

References

CASE Patient resubmits to surgery

In the case described at the beginning of this Editorial, the patient had her ovaries, but not her fallopian tubes, removed. Alone, bilateral oophorectomy decreased her risk of ovarian cancer and breast cancer (by curtailing production of ovarian hormones), but she remains at increased risk of fallopian tube and peritoneal carcinoma because she did not have her fallopian tubes removed. The patient is offered a second surgery to remove both fallopian tubes. She accepts this option.

What specific risk did the incomplete surgery pose to the patient? In 1 case series, among women at high risk of pelvic cancer, bilateral oophorectomy alone was associated with an 11.5% risk of peritoneal papillary serous carcinoma (PPSC) postoperatively. On the other hand, removing the ovaries and fallopian tubes was associated with no cases of PPSC.6

Most experts recommend that as much as possible of the fallopian tube be removed at surgery. Because most occult fallopian tube lesions have been reported in the fimbriated end of the tube, removing the interstitial portion is unnecessary. If surgical staging is indicated, it should be performed at surgery.

Pages

Recommended Reading

Many CP Cases Linked to Intrauterine Infection
MDedge ObGyn
Prevention Key in Postchildbirth Fecal Incontinence
MDedge ObGyn
Consider Risks of Not Treating Depression
MDedge ObGyn
Pregnancy May Mask Heart Disease Symptoms
MDedge ObGyn
Time Crucial for Success in Perimortem C-Section : A review says 98% of babies born within 5 minutes of maternal cardiac arrest are neurologically intact.
MDedge ObGyn
Low Placental Growth Factor May Mean Preeclampsia Later
MDedge ObGyn
Third-Trimester Glucose Levels Most Predictive of LGA Infant
MDedge ObGyn
Adjuvant Chemoendocrine Therapy Ups CV Risk : Resting echocardiography may not be sufficiently sensitive to detect subtle cardiac dysfunction.
MDedge ObGyn
Tamoxifen Superior to Raloxifene for Noninvasive Breast Ca in STAR Trial
MDedge ObGyn
Cardiovascular Risk From Radiotherapy Higher in Patients With Prior MI
MDedge ObGyn